English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
News
Interview Timothy Hughes
Truly global in focus - Interview with Timothy Hughes, chair of the iCMLf
July 2014 - “We wanted to spread the benefit of new knowledge, effective drugs and accurate monitoring beyond the developed world. This was our first and is still our highest priority”. (Tim Hughes)
Q1: Great advances have been made in the management of patients with CML during the last couple of years. Where do you currently still see the biggest challenges and how could we best meet those challenges?
The outlook for a newly diagnosed CML patient is very positive in 2014 – a complete turnaround from the situation they faced even in the 1990s. However we still see CML patients transform into blast crisis in the first one or two years of kinase inhibitor therapy. We must find ways to identify these patients before they transform and trial innovative approaches. This remains one of our biggest challenges.
Jane Apperley new iCMLf Director
Professor Jane Apperley becomes a new member of the
iCMLf Board of Directors
April, 2014 - The iCMLf is delighted to announce that Professor Jane Apperley has accepted our invitation to join the iCMLf Board of Directors as a new member. “She is a leading expert in CML monitoring and management and has been a strong supporter of the Foundation through her work with preceptors at the Hammersmith Hospital”, said Tim Hughes, chair of the iCMLf.
John Goldman Prize 2014
The inaugural iCMLf Goldman Prize is awarded to Professor Rüdiger
Hehlmann
February, 2014 - In addition to the Rowley Prize that the iCMLf awards annually to individuals that have made a major lifetime contribution to the understanding of the biology of CML, the iCMLf Directors have created a second prize. The recently launched Goldman Prize complements the Rowley Prize as a clinical equivalent by recognising lifetime contributions to the management of patients with CML. The new award has been created in memory of the late iCMLf chair to honour Professor Goldman´s commitment to clinical excellence in treating CML.
Nomination Tim Hughes iCMLf chair
Tim Hughes becomes the new iCMLf chair –
Jorge Cortes to chair the annual "John Goldman Conference on CML"
February 2014 - Following the sudden death of Professor John Goldman the iCMLf Directors have nominated Professor Tim Hughes as the next chairman of the foundation. Dr Hughes is one of the co-founders of the Foundation and has helped to shape the iCMLf’s strategy and programs for the past five years as member of the Board of Directors.
Rowley Prize 2014
The 2014 Rowley Prize is awarded to
Dr Owen N. Witte
February 2014 - In 2014 the iCMLf Rowley Prize for persons who have made major contributions to understanding the biology of CML is awarded to Dr Owen Witte, a Distinguished Professor of Microbiology, Immunology and Molecular genetics. Dr Witte is Director of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at the University of California Los Angeles (UCLA) and a Howard Hughes Medical Institute Investigator. He currently holds the UCLA Presidential Chair in Developmental Immunology.
Janet Rowley – 1925–2013
Janet Rowley – 1925–2013
February 2014 - It is with great sadness that we share the news of the death of Professor Janet Rowley. An inspiration and teacher to so many she will be greatly missed.
